ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

April 12, 1985

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987